Actelion does not see significant CVS hit to Opsumit sales

ZURICH, Aug 3 (Reuters) - Big U.S. pharmacy chain CVS

Health's move to jettison an Actelion drug from

a list of covered medications is not expected to have a

"meaningful impact" on the Swiss...

Read more